HONG KONG – 3Sbio Inc. announced a proposed asset purchase agreement worth $290 million for the contract development and manufacturing organization (CDMO) business of Canada's Therapure Biopharma Inc.
HONG KONG – The Indian government has just announced a move to cap prices on orthopedic knee implants. In a statement published on Aug. 16, the National Pharmaceutical Pricing Authority (NPPA) listed the ceiling price for each type of knee implants. The price range goes from ₹54,000 (US$841) to ₹114,000 (US$1,776).
HONG KONG – With a booming global market for attention deficit hyperactivity disorder (ADHD) drugs, Durect Corp. is on track to deliver a potentially new, profitable product. The company has achieved positive results in its phase III clinical study of the Oradur-methylphenidate extended-release (ER) capsule administered once a day.
HONG KONG – Japan's Chugai Pharmaceutical Co. Ltd. signed a collaborating agreement with the National Cancer Center of Japan to join forces in developing rare cancer cures and genomic medicines.
HONG KONG – With a booming global market for attention deficit hyperactivity disorder (ADHD) drugs, Durect Corp. is on track to deliver a potentially new, profitable product. The company has achieved positive results in its phase III clinical study of the Oradur-methylphenidate extended-release (ER) capsule administered once a day.
